Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Anti-dumping duty...

    Anti-dumping duty likely on chemical imported from China, Turkey

    Written by Ruby Khatun Khatun Published On 2018-02-25T10:15:46+05:30  |  Updated On 25 Feb 2018 10:15 AM IST
    Anti-dumping duty likely on chemical imported from China, Turkey

    New Delhi: The government is likely to impose anti-dumping duty of up to USD 211 per tonne on a chemical used in textiles and pharma industry, imported from China and Turkey for a period of five years.


    Imposition of the duty on 'Dimethylacetamide' would provide level-playing field to the domestic industry and also guard them from cheap imports.


    Following complaints from domestic companies, the Directorate General of Anti-dumping and Allied Duties (DGAD), under the commerce ministry, investigated the matter.


    In its final findings of the probe, the directorate has concluded that the product has been exported to India from these two countries below normal values, and due to this the domestic industry has suffered material injury.


    "The authority recommends imposition of definitive anti-dumping duty...so as to remove the injury to the domestic industry," the DGAD said in a notification.


    DGAD has recommended the duty in the range of USD 48 per tonne and USD 211 per tonne. The finance ministry takes the final call on the imposition of the duty.


    Rashtriya Chemicals and Fertilizers Ltd and Balaji Amines Ltd had filed the application for initiation of the anti-dumping investigations.


    Countries carry out anti-dumping probe to determine whether their domestic industries have been hurt because of a surge in cheap imports.


    As a counter measure, they impose duties under the multilateral regime of WTO.


    The duty is also aimed at ensuring fair trading practices and creating a level-playing field for domestic producers with regard to foreign producers and exporters.


    India has already imposed anti-dumping duty on several products to check cheap imports from countries including China, with which India has a major concern of widening trade deficit.


    The deficit with China stood at USD 36.73 billion during April-October this fiscal.


    The country has imposed the duty on as many as 98 products, as on December 27 last year, imported from China.

    Anti-dumping dutyBalaji Amines Ltdchemical importchinaDimethylacetamideDirectorate General of Anti-Dumping and Allied Dutiesdomestic industryinvestigationsPharma IndustryRashtriya Chemicals and Fertilizers LtdTurkeyWTO
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok